title: EGFR exon 19 insertions show good response to gefitinib, but short time to progression in Japanese patients.
authors.affiliation: Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
authors.forename: Jangchul
authors.initials: J
authors.lastname: Park
authors.forename: Chiaki
authors.initials: C
authors.lastname: Kondo
authors.forename: Junichi
authors.initials: J
authors.lastname: Shimizu
authors.forename: Yoshitsugu
authors.initials: Y
authors.lastname: Horio
authors.forename: Kimihide
authors.initials: K
authors.lastname: Yoshida
authors.forename: Toyoaki
authors.initials: T
authors.lastname: Hida
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D005091:Exons / Q000235:genetics*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; C512478:EGFR protein, human; D066246:ErbB Receptors; D000077156:Gefitinib